Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab

MLA

L. P. Ananieva, et al. “Short-Term Absolute B-Cell Counts Monitoring in Systemic Sclerosis Patients Treated with Rituximab.” Научно-Практическая Ревматология, vol. 58, no. 4, Sept. 2020, pp. 395–400. EBSCOhost, https://doi.org/10.47360/1995-4484-2020-395-400.

APA

L. P. Ananieva, L. A. Garzanova, O. V. Desinova, O. A. Koneva, M. N. Starovoytova, O. B. Ovsyannikova, A. P. Aleksankn, & S. I. Glukhova. (2020). Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab. Научно-Практическая Ревматология, 58(4), 395–400. https://doi.org/10.47360/1995-4484-2020-395-400

Chicago

L. P. Ananieva, L. A. Garzanova, O. V. Desinova, O. A. Koneva, M. N. Starovoytova, O. B. Ovsyannikova, A. P. Aleksankn, and S. I. Glukhova. 2020. “Short-Term Absolute B-Cell Counts Monitoring in Systemic Sclerosis Patients Treated with Rituximab.” Научно-Практическая Ревматология 58 (4): 395–400. doi:10.47360/1995-4484-2020-395-400.